TARGET AUDIENCE
This educational activity is intended for oncologists, radiation therapists, thoracic surgeons, pulmonologists and other physicians in active clinical practice interested and/or involved in the management of patients with non-small cell lung cancer.

 

CONTINUING MEDICAL EDUCATION
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)^TM Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

LEARNING OBJECTIVES
After attending this symposium, participants should be able to:

• Discuss the heterogeneous nature of stage III NSCLC and define subclasses within this broad group of tumors.


• Explain the role of surgery and radiotherapy in the management of locally advanced NSCLC.


• Evaluate clinical evidence for combined modality therapy in locally advanced and advanced NSCLC.


• Determine appropriate management options for advanced NSCLC, including the incorporation of newer therapeutic agents.

Jeffrey Bogart, MD Upstate Medical Center Syracuse, New York   Hak Choy, MD University Of Texas Southwestern Medical Center Dallas, Texas   Walter Curran, Jr., MD, FACR Emory University Atlanta, Georgia   Sarita Dubey, MD University of California, San Francisco San Francisco, California   Laurie Gaspar, MD, FACR, MBA University of Colorado HSC Denver, Colorado   Ramaswamy Govindan, MD Washington University in St. Louis School of Medicine St. Louis, Missouri

David Harpole Jr., MD Duke University Medical Center Durham, North Carolina   David Jablons. MD University of California San Francisco, California   Renato G. Martins, MD, MPH University of Washington Seattle Cancer Care Alliance Seattle, Washington   Vivek Mehta, MD Department of Radiation Oncology Seattle, Washington   Ronald Natale, MD Cedars-Sinai Comprehensive Cancer Center Santa Monica, California   Luis E. Raez, MD Director Hematology/Oncology Clinics   University of Miami School of Medicine Miami, Florida

Suresh Ramalingam, MD Emory University School of Medicine Atlanta, Georgia   Walter Scott, MD, FACS Fox Chase Cancer Center Philadelphia, Pennsylvania   Robert D. Timmerman, M.D. Department of Radiation Oncology University of Texas Southwestern Dallas, Texas   Eric Vallieres, MD, FRCSC Swedish Cancer Institute Seattle, Washington   Henry Wagner, MD Pennsylvania State Cancer Institute Hershey, Pennsylvania

(* Please note: All locations except for Dallas will follow this 6:30 pm - 9:00 pm agenda. The Dallas agenda will begin at 6:00 pm and conclude at 8:30 pm.)

6:30 pm
Reception

 

6:45 pm
Introduction

 

7:00 pm – 8:20 pm
Clinical Challenges in Stage III NSCLC

 

7:00 pm
Surgical Evaluation in Stage III NSCLC

 

7:20 pm
Recent Advances in Radiation Therapy

 

7:40 pm
Combined Modality Therapy

 

8:00 pm
Discussion

 

8:20 pm
Emerging Data in Advanced NSCLC

 

8:45 pm
Discussion

 

9:00 pm
Adjourn

 

************

 

*Dallas Agenda

 

6:00 pm
Reception

 

6:15 pm
Introduction

 

6:30 – 7:50 pm
Clinical Challenges in Stage III NSCLC

 

6:30 pm
Surgical Evaluation in Stage III NSCLC

 

6:50 pm
Recent Advances in Radiation Therapy

 

7:10 pm
Combined Modality Therapy

 

7:30 pm
Discussion

 

7:50 pm
Emerging Data in Advanced NSCLC

 

8:15 pm
Discussion

 

8:30 pm
Adjourn

This is a complimentary educational dinner meeting for physicians. There is no cost to attend this activity or to obtain CME credits. You may register online at www.imedex.com.

Contemporary Therapeutic Strategies in Advanced Non-Small Cell Lung Cancer
Complimentary Dinner Series Meeting
An interactive series of dinner meetings where experts in the field of thoracic oncology will share the latest clinical and practical results and provide guidelines to other clinicians who manage patients with NSCLC on a day-to-day basis.  Select the most convenient city for complete details:

DATES/LOCATIONS (click on the dates for meeting information):

Tuesday, August 12, 2008
Wild Ginger
1401 Third Avenue (Union Street)
Seattle, Washington
Tel.: (206) 623 4450

Wednesday, August 13, 2008
103 West
103 West Paces Ferry Road (Buckhead)
Atlanta, Georgia
Tel.: (404) 240 6620

Wednesday, August 13, 2008
Grace
7360 Beverly Boulevard
Los Angeles, California
Tel.: (323) 934 4400

Tuesday, August 19, 2008
Craftbar
900 Broadway
New York, New York
Phone: (212) 461 4300

Wednesday, August 20, 2008
Gibson's Steakhouse
5464 N. River Road (Rosemont)
Chicago, Illinois
Tel.: (847) 928 9900

Tuesday, August 26, 2008
Scala's Bistro
450 Powell Street (Sutter Street)
San Francisco, California
Tel.: (415) 395 8506

Wednesday, August 27, 2008
The Landmark in the Warwick Melrose Hotel
3015 Oak Lawn Ave
Dallas, Texas
Tel.: (214) 521 5151

Tuesday, September 9, 2008
Frazer’s
1811 Pestalozzi
St. Louis, Missouri
Tel.: (314) 773 8646

Wednesday, September 10, 2008
Table 8 (South Beach)
1458 Ocean Drive
Miami Beach, Florida
Tel.: (305) 695 4114

Wednesday, September 10, 2008
The Oval Room
800 Connecticut Avenue NW
Washington, DC
Tel.: (202) 785 9863

SERIES CHAIR:
Ramaswamy Govindan, MD
Washington University in St. Louis
School of Medicine
St. Louis, Missouri

ORGANIZER:
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

 

Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.

In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.

©2008 Imedex^®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.

The following companies
have provided unrestricted
educational grants in support
of this series:

 

 

 

Genentech BioOncology and OSI Oncology